Connect with us

Hi, what are you looking for?

Thursday, Jul 9, 2026
Mugglehead Investment Magazine
Alternative investment news based in Vancouver, B.C.
Sadot Group hit hard after Fugazi report deems stock worthless
Sadot Group hit hard after Fugazi report deems stock worthless
Sadot's Brazil team in 2025. Photo credit: Sadot Group

Stock News

Sadot Group hit hard after Fugazi report deems stock worthless

The firm’s assessments have an influential track record

Fugazi Research reports tend to strike with the force of a wrecking ball, leaving once-hyped shares in ruins as investors draw their attention to allegations of hollow fundamentals.

The latest victim, Sadot Group Inc (NASDAQ: SDOT), illustrates this trend well. Following Fugazi Research’s publication on Jul 6, the Nasdaq-listed company’s shares plummeted. They crashed as much as 72 per cent intraday on Wednesday, hitting a low near US$11.00 from the previous close around US$40. Trading halted five times amid this chaos.

As the report details aligns with Sadot’s recent filings, Fugazi’s core claims appear well-supported by public records and carry significant weight. The short-seller accuses Sadot of making moves that have left it as a revenue-less shell burdened by massive liabilities. It highlights how the firm’s agri-commodity trading business went from raking in US$132.2 million in the first quarter of 2025 to nothing in Q1 of 2026, among other serious concerns.

Sadot’s balance sheet currently shows total liabilities of US$60.8 million against just US$2.4 million in assets, producing a US$58.4 million shareholders’ deficit. Management has disclosed substantial doubt about continuing as a going concern. Figures like these have made Fugazi deem the stock to hold zero fundamental value.

Fugazi has also explained that new “acquisitions,” such as a UAE software platform for US$12 million (mostly non-cash paper) and an option on California real estate, look like classic narrative shifts to sustain trading interest while diluting shareholders through reverse splits and share expansions.

Sadot Group started as a restaurant chain that ran places like Muscle Maker Grill in the United States. Between 2022 and 2023 it switched direction and became a trader of farm commodities such as soybeans, wheat, corn and other grains. The company bought these crops from farmers or suppliers around the world, sold them on to buyers, and even tried running its own farms. It tried to look like big players such as Archer-Daniels-Midland Co (NYSE: ADM) (FRA: ADM) and Bunge Global SA (NYSE: BG) (FRA: Q23). However, it has since sold or lost most of its operations and racked up heavy losses of about US$93.5 million in fiscal 2025.

Fugazi Research operates as an independent short-selling outfit that publishes detailed, data-heavy reports targeting microcaps and troubled names. It builds cases from SEC filings, court records and operational realities. While short-sellers face scepticism, Fugazi’s analyses on Sadot demonstrate strong grounding and have proven influential in exposing balance-sheet weaknesses.

Fugazi’s work has repeatedly hammered stocks. Its May report on cannabis operator Akanda Corp (NASDAQ: AKAN) (FRA: Y232) triggered a 32 per cent plunge, highlighting dilution and a lack of viable operations. Moreover, a March critique of Energous Corp (NASDAQ: WATT) (FRA: 116) contributed to downward pressure by underscoring a dilution-driven model over genuine revenue.

Similar reports on other names have spotlighted unsustainable floats and narrative-driven volatility, often sending shares down considerably.

Read more: Fugazi short report sends Akanda tumbling after cannabis rescheduling rally

 

Follow Mugglehead on X

Like Mugglehead on Facebook

Follow Rowan Dunne on X

Follow Rowan Dunne on LinkedIn

rowan@mugglehead.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Technology

Tesollo will be the first humanoid hand-dedicated firm to go public

Gold

His predictions come amid a bullish long-term consensus

Medical and Pharmaceutical

Cortigent uses brain and retina implant tech to help blind people navigate better

Mining

New Brunswick started looking for a developer to restart the past-producing site in April